|
|
Phoenix Data Systems Catches the Wave with Full-Service EDCPublished by: IDC Published: Jun. 28, 2006 - 10 Pages Table of ContentsTable of Contents In this perspective Situation Overview Figure: The Impact of Insufficient EDC Resources Adrift on a Sea of Data Figure: Technology Learning Curve Changing Tides Catching the Full-Service EDC Wave Figure: Full-Service EDC Accelerates Adoption PDS Express Well-Positioned Future Outlook Essential Guidance The Next Wave: Adaptive Trial Designs Learn More Glossary AbstractThis Health Industry Insights Perspective examines the cost of managing clinical data without the availability of adequate resources and proposes full-service electronic data capture (EDC) as a solution to help sponsors navigate through the data storm raging in their clinical trials. As the complexity of clinical trials continues to grow, so too does the amount of data being collected and managed. Life science companies conducting clinical trials find themselves awash in both clinical and nonclinical data. Initially, data management contract research organizations (CROs) were successful in mitigating the resource impact of this changing tide. And technology, specifically electronic data capture, has the potential to assist sponsors in managing the exponentially increasing volume of data. But neither EDC nor data management CROs alone are an adequate solution to the problem. Sponsors must learn how to fully leverage EDC, which adds an unexpected layer of complexity if sponsors are not prepared. For sponsors to remain afloat and not be continually swamped by the increasing amount of data flowing into their organizations, they must be able - as is Phoenix Data Systems (PDS), a full-service EDC provider - to fulfill the following requirements: Cultivate experienced clinical and data management resources that can be engaged as needed to help guide their clinical trials. Implement an eclinical technology framework featuring an EDC application that is scalable yet flexible enough to support midstudy corrections and adaptive trials. Embrace the deployment of EDC as an opportunity to reengineer key clinical processes.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||